logo
Could Silicon Valley's Indian CEOs get the Intel treatment?

Could Silicon Valley's Indian CEOs get the Intel treatment?

Time of India2 days ago
Academy
Empower your mind, elevate your skills
According to President Donald Trump , the rise of Intel Corp.'s CEO, Lip-Bu Tan, is 'an amazing story.' That's as much payoff as Tan can expect from his emergency meeting with Trump, who last week had demanded he 'resign, immediately' because he was 'highly CONFLICTED.'We don't know if Intel will be able to convince the administration to view its CEO with less disfavor. Some in Washington are concerned about Malaysian-born Tan's long history supporting and investing in the Chinese tech sector. And questions about how Intel intends to live up to government controls on the export of high-end technology under his leadership are, given this history, not unreasonable.Nevertheless, it's a problematic precedent. That should worry Silicon Valley's powerful Indian diaspora in particular.Take a step back and ask yourself: Is there anything inherently questionable about a tech firm appointing a CEO with an eye for innovative and effective startups? At his venture capital firm Walden International, Tan invested in more than 100 Chinese companies, including an early bet on Semiconductor Manufacturing International Corp. Normally, this would be a count in his favor.The problem is a fear, both in Washington and in Silicon Valley, that the US and Chinese tech ecosystems are not complements but rivals. This wasn't the case in 2001, when Walden put money in SMIC. But it's certainly the general feeling today.Indian tech leaders have managed to escape similar scrutiny precisely because the tech scene here is seen as providing low-end support to US industry, not high-value competition. But how long will that be true? And what happens if it changes?New Delhi is not happy being a supporting player in the AI revolution. The country has begun to stockpile chips — compute capacity has passed 34,000 GPUs in May, according to government officials — and has already selected national champions it intends to support.Given the relative dynamism of India's startups, its tech sector will at some point produce a few success stories that challenge the dominance of US companies. That's good news for Indians. But it might make things more difficult for Indian-Americans in Silicon Valley.Across corporate America, but particularly in Big Tech, people of Indian descent have been disproportionately successful as leaders, more so perhaps than their colleagues of Chinese heritage. Think of Alphabet Inc.'s CEO Sundar Pichai, Microsoft Corp.'s Satya Nadella, Adobe Inc.'s Shantanu Narayen and IBM Corp.'s Arvind Krishna, for example. As Intel's troubles following its choice of Tan demonstrate, this might partly be because their home nation is not considered a strategic competitor to the US.That image is slowly changing in the Trump era. Indians in Silicon Valley have already discovered that things are bit harder now. H1-B visas, for example, are a political hot-button issue, and provided the first wedge in the relationship between Trump and Elon Musk. Trump has already made it clear that he doesn't want his backing of Big Tech to mean any jobs for Indians: 'Many of our largest tech companies have reaped the blessings of American freedom while building their factories in China, hiring workers in India and stashing profits in Ireland,' he said at a tech summit last month, adding: 'Under President Trump, those days are over.'So far, corporate leaders have not had to answer any questions about their distance from the sector back home. But the political environment will get more difficult to navigate as India's tech companies achieve greater autonomy and efficiency, and the Trump administration reworks policy. The 50% tariff rate that New Delhi has been threatened with reveals how the president's mind works: He may not see India's trajectory as fundamentally different from China's, and his mercantilist soul rebels at the thought of collaborating with a future rival.An age of economic nationalism and competitive industrial policy will always be tough on cosmopolitan minorities. 'Dual loyalty' accusations gain no traction in an age of prosperous globalization, but have a long and dark history when populists seize power and turn back the clocks.The diaspora should not look at Tan's attempts to win over Trump with satisfaction or superiority. They might be next. Nor should they assume that they'll always be able to avoid similar accusations. The only reason they haven't faced them so far is that nobody thought their connections back home could ever be a problem. Here's the hard truth: India's success will mean the end of Silicon Valley's Indian-American golden age.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dow briefly hits record high on UnitedHealth boost; Trump-Putin meeting in focus
Dow briefly hits record high on UnitedHealth boost; Trump-Putin meeting in focus

Mint

timea few seconds ago

  • Mint

Dow briefly hits record high on UnitedHealth boost; Trump-Putin meeting in focus

Indexes: Dow up 0.3%, S&P 500 down 0.11%, Nasdaq off 0.27% UnitedHealth surges after Berkshire Hathaway investment Bank of America shares down on Berkshire share sale Applied Materials drops on weak China demand forecast Investors monitor Trump-Putin summit at Alaska By Johann M Cherian, Sanchayaita Roy and Saeed Azhar Aug 15 - The blue-chip Dow briefly hit a record high on Friday, as UnitedHealth's shares jumped after Berkshire Hathaway raised its stake in the health insurer, while investors assessed mixed data to determine the Federal Reserve's next monetary policy move. A meeting between U.S. President Donald Trump and Russian counterpart Vladimir Putin was also on the radar, with markets hoping it could pave the way for a resolution to the Ukraine conflict and determine the outlook for crude prices. The meeting is scheduled to take place at 1900 GMT. UnitedHealth Group gained almost 14% and was on track to log its biggest daily rise since 2008 after Warren Buffett's company revealed a new investment in the health insurer, while Michael Burry's Scion Asset Management also turned more bullish on the company. Rising costs in the broader healthcare sector and about a 40% slump in UnitedHealth's shares this year have left the Dow lagging its Wall Street peers on the road to record highs. The price-weighted index last scaled an all-time high on December 4. The healthcare sector gained 1.8% on Friday and is on track for its best weekly performance since October 2022. At 2:04 p.m. the Dow Jones Industrial Average rose 134.90 points, or 0.30%, to 45,046.70, the S&P 500 lost 7.43 points, or 0.11%, to 6,461.11 and the Nasdaq Composite lost 57.72 points, or 0.27%, to 21,652.95. More broadly, Wall Street's main stock indexes are on track for their second week of gains, buoyed by expectations that the Fed could restart its monetary policy easing cycle with a 25-basis-point interest rate cut in September. The central bank last lowered borrowing costs in December and said U.S. tariffs could add to price pressures. However, recent labor market weakness and signs that tariff-induced inflation was yet to reflect in headline consumer prices have made investors confident of a potential dovish move next month. "The question is, has the tariff gotten into the price of goods yet? And it appears that there hasn't," said Joe Saluzzi, co-head of equity trading at Themis Trading. Saluzzi also said while markets have largely priced in a September rate cut, investors might be overlooking risks, with low volatility and rich valuations pointing to a sense of complacency. In a mixed day for economic data, a report showed retail sales in July rose as expected, but consumer confidence and factory production numbers indicated tariffs were taking a toll on other pockets of the economy. Chicago Fed President Austan Goolsbee was also cautionary in his remarks. Trump has said he will unveil tariffs on steel and semiconductors next week. Among other stocks that were on the move, Applied Materials tumbled 14% after the chip equipment maker issued weak fourth-quarter forecasts. Shares of Bank of America dropped 1.4% after Berkshire Hathaway reduced its stake in the second-biggest U.S. lender by 4.2% to 605.3 million shares. It still owns about an 8% stake in BofA. Intel surged 5.7% after a report said the Trump administration was in talks for the U.S. government to potentially take a stake in the chipmaker. Declining issues outnumbered advancers by a 1.22-to-1 ratio on the NYSE. On the Nasdaq, declining issues outnumbered advancers by a 1.29-to-1 ratio. The S&P 500 posted 10 new 52-week highs and no new lows, while the Nasdaq Composite recorded 77 new highs and 72 new lows. This article was generated from an automated news agency feed without modifications to text.

Washington DC sues Trump administration over 'hostile takeover' of police
Washington DC sues Trump administration over 'hostile takeover' of police

India Today

timea few seconds ago

  • India Today

Washington DC sues Trump administration over 'hostile takeover' of police

Washington DC's government has gone to court to stop "hostile takeover" of its police department by the Trump administration. On Friday, District of Columbia attorney general Brian Schwalb asked for an emergency order from a judge to block the federal government's new control over local law legal fight began hours after US attorney general Pam Bondi issued an order on Thursday night that gave the federal government the power to appoint a new head of the city's Metropolitan Police Department (MPD).advertisementSchwalb alleged that President Donald Trump's team is going far beyond its legal powers and breaking the rules set for the nation's CHIEF APPOINTED AS CAPITAL'S TOP COP According to the Trump administration's plan, the head of the Drug Enforcement Administration (DEA), Terry Cole, would take over as "emergency police commissioner" in Washington DC. Bondi said Cole would have "all powers and duties" of the city's police added that MPD staff would have to get Cole's approval before giving any orders. This created confusion about the role of Pamela Smith, the current police chief appointed by the city's mayor, Muriel leaders immediately opposed the move and filed a lawsuit to stop it. They say the decision undermines local democracy and breaks the Home Rule Act, which gives Washington DC limited AND SCHWALB CHALLENGE WHITE HOUSE MOVEMayor Bowser criticised the takeover on Thursday night. She posted on social media that "there is no statute that gives a federal official control over the District's personnel."Bowser also shared a letter from Schwalb to Chief Smith. In it, Schwalb said Bondi's order was "unlawful" and told Smith she was "not legally obligated to follow it." He instructed MPD officers to follow the orders of the police chief appointed by the mayor — not any federal takeover comes four days after Trump sent National Guard troops into the city. The president had declared a crisis of crime and homelessness in Washington defended the decision, saying the city's police needed stronger leadership to handle public safety. She claimed that Cole's appointment would make operations more effective and allow better coordination with federal OVER DC'S SANCTUARY CITY RULESThe tension grew after Chief Smith issued an order telling MPD officers to share information about people not in custody with federal agencies, including the Department of Homeland Security (DHS) and Immigration and Customs Enforcement (ICE).Since Washington DC is a "sanctuary city", local law still prevents police from giving immigration authorities details about undocumented people in custody. Police also cannot arrest someone solely for their immigration status or allow immigration officers to interview detainees.- EndsWith inputs from Reuters

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store